hapabapa/iStock Editorial via Getty Images
A U.S. federal court has approved a settlement between Novo Nordisk (NVO) and Minnesota ending a longstanding litigation that accused three leading insulin manufacturers of charging excessive prices for the vital diabetes therapy.
According to Bloomberg News, the U.S. District Judge Brian
